Featured Research

from universities, journals, and other organizations

Lower Hispanic participation in Medicare drug benefit may point to barriers

Date:
May 5, 2014
Source:
University of Rochester Medical Center
Summary:
Hispanic seniors are 35 percent less likely to have prescription drug coverage despite the existence of the Medicare Prescription Drug Plan -- also known as Part D -- and the availability of assistance to help pay insurance premiums. Medicare Part D was implemented in 2006 to help make prescription drugs -- and premiums for prescription drug insurance plans -- more affordable to seniors.

Hispanic seniors are 35 percent less likely to have prescription drug coverage despite the existence of the Medicare Prescription Drug Plan -- also known as Part D -- and the availability of assistance to help pay insurance premiums. That is the finding of a study released today in the journal Health Affairs.

"These results indicate that disparities in prescription drug coverage exist between Hispanic and white Medicare beneficiaries, despite the existence of a potentially universal entitlement program," said Brian McGarry, a graduate student in the Department of Public Health Sciences at the University of Rochester School of Medicine and Dentistry. "This study suggests that, in spite of the overall success of the Part D program, future policies need to focus on the disproportionately low enrollment of vulnerable populations."

McGarry, Robert Strawderman, Sc.D., the chair of the University of Rochester Department of Biostatistics and Computational Biology, and Yue Li, Ph.D., an associate professor in the Department Public Health Sciences, co-authored the study.

Medicare Part D was implemented in 2006 to help make prescription drugs -- and premiums for prescription drug insurance plans -- more affordable to seniors. While many seniors are automatically enrolled in Medicare Part A and Part B, which cover hospital and outpatient care, at age 65, they are often required to independently choose a drug benefit plan.

Seniors who receive both Medicare and Medicaid benefits are automatically assigned a drug plan. Seniors below a certain income threshold, but not receiving Medicaid, are eligible for subsidies to support drug coverage; however, they have to apply for these subsidies through a separate process.

If seniors do not choose a drug coverage plan, they are subject to financial penalties that increase the longer they wait to enroll. Previous studies have calculated that enrolling in Part D at the age of 65 is optimal for about 98 percent of Medicare beneficiaries, given the low premiums and penalties for late sign up.

Despite the financial incentive to enroll in drug coverage, the process itself can be a barrier to enrollment. Part D coverage was designed to be offered through private insurers. While the goal of this approach was to promote competition and lower cost, the result is an often bewildering list of coverage options. Depending upon where they live, seniors can be confronted with an average of 30 different drug coverage plans to choose from that offer a variety of premiums, co-pays, pharmacy restrictions, and specific list of drugs that are covered.

Navigating this complex process requires patience and health and financial "literacy," meaning the ability to understand the coverage options and conduct a cost-benefit analysis depending upon one's individual circumstances.

The researchers used 2011 data from the National Health and Aging Trends Study, a new and highly detailed source of data about Medicare beneficiaries which includes information on demographic characteristics, finances, and health. The researchers found that Hispanic seniors were 35 percent less likely than whites to have any form of drug coverage after controlling for demand for prescription drugs and ability to afford a plan. This is despite the fact that an estimated 65 percent of Hispanics without coverage were eligible to receive premium support.

The general complexity of applying for premium subsidies and the financial skills required to accurately determine the value of drug coverage and choose from among a large number of plans may contribute to this phenomenon.

Furthermore, while coverage information is widely available in Spanish, the disparity in Part D enrollment could be indicative of a cultural disconnect or the shortcomings of outreach efforts to effectively educate and assist Hispanic seniors with these decisions. Similar challenges recently came to light as many states struggled to enroll Hispanics for health coverage under the Affordable Care Act.

With all that is known about the adverse health and economic effects associated with a lack of prescription drug coverage, the authors point out that -- with a rapidly growing population of Hispanic seniors -- addressing this disparity is a critical public health priority.


Story Source:

The above story is based on materials provided by University of Rochester Medical Center. Note: Materials may be edited for content and length.


Journal Reference:

  1. B. E. McGarry, R. L. Strawderman, Y. Li. Lower Hispanic Participation In Medicare Part D May Reflect Program Barriers. Health Affairs, 2014; 33 (5): 856 DOI: 10.1377/hlthaff.2013.0671

Cite This Page:

University of Rochester Medical Center. "Lower Hispanic participation in Medicare drug benefit may point to barriers." ScienceDaily. ScienceDaily, 5 May 2014. <www.sciencedaily.com/releases/2014/05/140505211349.htm>.
University of Rochester Medical Center. (2014, May 5). Lower Hispanic participation in Medicare drug benefit may point to barriers. ScienceDaily. Retrieved July 25, 2014 from www.sciencedaily.com/releases/2014/05/140505211349.htm
University of Rochester Medical Center. "Lower Hispanic participation in Medicare drug benefit may point to barriers." ScienceDaily. www.sciencedaily.com/releases/2014/05/140505211349.htm (accessed July 25, 2014).

Share This




More Health & Medicine News

Friday, July 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
Can Watching TV Make You Feel Like A Failure?

Can Watching TV Make You Feel Like A Failure?

Newsy (July 24, 2014) A study by German researchers claims watching TV while you're stressed out can make you feel guilty and like a failure. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins